Hondramin [Cartilage Peptides]

Instructions for Hondramin [Cartilage Peptides]

English product name
Hondramin

Release form
Tablets coated with an intestinal-soluble shell

Description

Tablets covered with a intestinal-soluble shell from light cream to cream color, round shape, diameter 7 mm, weight 0.155 mg; a specific smell is possible.

1 tab.
Hondramin powder* 10 mg
* complex of polypeptides and nucleic acids derived from cartilage of cattle and pigs.

[PRING] lactose (filler), granulated sugar (thickener), potato starch (opener), calcium stearate (anti-tracking agent), methacrylic acid copolymer dispersion (intestinal soluble coating), propylene glycol (emulsifier).

20 pcs. - blister packs (2) - cardboard packs.

Clinical-pharmacological groups / Group affiliation
BAD - source of polypeptides and nucleic acids

Storage Conditions
The product should be stored in a dry place, inaccessible to children at a temperature of 2°C to 25°C.

Best before date
Shelf life - 3 years from the date of manufacture.

Pharmacological effect Hondramin

The components for Hondramin derived from cattle cartilage are a complex of proteins and nucleoproteins that selectively affect cartilage cells, which normalizes metabolic processes in chondrocytes and reduces the possibility of various joint lesions.
Hondramin clinical trials were conducted in 120 patients with osteoarthrosis of knee joints, osteochondrosis of spine and systemic osteoporosis.
The effectiveness of Hondramin was assessed on the basis of the dynamics of subjective complaints and objective indicators of laboratory and instrumental studies, as well as control of the functional state of the musculoskeletal system.

During clinical trials, it was found that course administration of Chondramine as part of complex therapy helped to reduce pain syndrome and joint stiffness in patients. The most characteristic action of Chondramine was the reduction of pain syndrome and an increase in the volume of movement in the affected joints. In all patients, the incidence of pathological symptoms, usually characterized by significant resistance to therapy, was significantly reduced against the background of Chondramine. The degree of clinical effect depended on the stage of onset: older and older persons showed less progress, but such subjective feelings were considered to be very favourable for older patients.

Chondramine® is recommended for accelerating cartilage repair processes in case of inflammatory and metabolic-dystrophic lesions of the joints of the limbs and spine, poor nutrition, effects on the body of various extreme factors, as well as for severe physical exertion and in sport of superior achievements. Chondramine® is recommended for older and older persons to maintain normal functioning of the musculoskeletal system.
Chondramine® is a natural product, does not contain preservatives, dyes and flavors.

Testimony Hondramin

• As a biologically active food additive - a source of polypeptides and nucleic acids in:
• Degenerative-dystrophic diseases of joints of limbs and spine;
• Effects of joint and limb injuries;
• Arthropathy of different etiology;
• systemic connective tissue diseases;
• states after extreme physical exertion;
• in pre- and post-operative period for joint operations;
• for systemic prevention of bone-joint disorders in sport of higher achievements.

Method of use, course and dosage

Chondramine® is recommended to take 10-15 minutes before eating, drinking water without chewing.
Adults are prescribed 1-3 tab. 2-3 times/day.
Duration of application - 30-45 days. It is optimal to conduct a second course in 3-6 months.